Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Oper. in, Oper. out

Operations: NOMESCO codes CKD65CKD05

Check pre-conditions None

Include endpoints None

diagram bullet diagram downward connector

Check conditions

DIABETES_FG

Apply sex-specific rule None

diagram downward connector DM_EYE_OPER_REMOVAL_VITR_INJECT_DRUG

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals - - -
Unadjusted prevalence (%) - - -
Mean age at first event (years) - - -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: DM_EYE_OPER_REMOVAL_VITR_INJECT_DRUG – Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity
GWS hits:

Survival analyses between endpoints

Plot

before Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity
after Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity